Newcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi Post author:Sam Post published:January 31, 2018 Post category:BioPharma Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi. Source: BioSpace You Might Also Like Up-and-Coming Chinese Biotech BeiGene Gets $750M Worth of Love From U.S. Investors January 18, 2018 SpineGuard Raises ???2 Million Of Fresh Equity Finance April 6, 2017 Eli Lilly's Taltz Succeeds in Key Phase III Ankylosing Spondylitis Trial February 12, 2018